Advisor Group Holdings Inc. raised its stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) by 268.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,102 shares of the medical device company’s stock after acquiring an additional 8,817 shares during the quarter. Advisor Group Holdings Inc.’s holdings in Cardiovascular Systems were worth $517,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Altshuler Shaham Ltd acquired a new stake in Cardiovascular Systems in the 1st quarter valued at about $37,000. Versant Capital Management Inc increased its position in Cardiovascular Systems by 32.9% in the 2nd quarter. Versant Capital Management Inc now owns 1,353 shares of the medical device company’s stock valued at $58,000 after acquiring an additional 335 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Cardiovascular Systems in the 1st quarter valued at about $187,000. Mutual of America Capital Management LLC increased its position in Cardiovascular Systems by 6.9% in the 1st quarter. Mutual of America Capital Management LLC now owns 5,368 shares of the medical device company’s stock valued at $206,000 after acquiring an additional 348 shares in the last quarter. Finally, 6 Meridian acquired a new stake in Cardiovascular Systems in the 2nd quarter valued at about $210,000. Hedge funds and other institutional investors own 94.30% of the company’s stock.
Cardiovascular Systems stock opened at $34.72 on Wednesday. The company’s 50 day simple moving average is $36.99 and its 200 day simple moving average is $38.69. Cardiovascular Systems, Inc. has a fifty-two week low of $33.39 and a fifty-two week high of $48.28. The firm has a market capitalization of $1.40 billion, a price-to-earnings ratio of -102.11 and a beta of 0.86. The company has a debt-to-equity ratio of 0.08, a current ratio of 5.21 and a quick ratio of 4.62.
Several research analysts have recently issued reports on the stock. SVB Leerink set a $38.75 target price on shares of Cardiovascular Systems and gave the company a “buy” rating in a research note on Friday, July 23rd. Northland Securities reaffirmed a “buy” rating and issued a $45.00 target price on shares of Cardiovascular Systems in a research note on Friday, July 16th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $44.95.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St.
Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.